Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -24.84% | -1.76% | 11.56% | 6.28% | -16.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.84% | -1.76% | 11.56% | 6.28% | -16.12% |
| Cost of Revenue | 10.84% | 36.67% | 10.24% | 24.91% | -13.80% |
| Gross Profit | -45.69% | -24.22% | 12.38% | -2.24% | -17.44% |
| SG&A Expenses | 36.12% | 46.57% | 33.56% | 15.77% | 8.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.18% | 45.42% | 30.71% | 16.75% | 5.14% |
| Operating Income | -59.88% | -66.45% | -39.95% | -22.32% | -19.07% |
| Income Before Tax | 51.31% | -59.25% | -37.90% | -16.06% | -84.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 51.31% | -59.25% | -37.90% | -16.06% | -84.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.31% | -59.25% | -37.90% | -16.06% | -84.38% |
| EBIT | -59.88% | -66.45% | -39.95% | -22.32% | -19.07% |
| EBITDA | -60.04% | -66.69% | -40.02% | -22.89% | -20.31% |
| EPS Basic | -50.00% | -300.00% | -200.00% | -100.00% | -100.00% |
| Normalized Basic EPS | 100.00% | -- | -- | -- | -- |
| EPS Diluted | -50.00% | -300.00% | -200.00% | -100.00% | -100.00% |
| Normalized Diluted EPS | 100.00% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 2.34% | 1.37% | 1.29% | 0.91% | 0.83% |
| Average Diluted Shares Outstanding | 99.92% | 99.05% | 99.34% | 99.11% | 0.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |